Clinical review report: Dapagliflozin (Forxiga)

The objective of this review was to perform a systematic review of the beneficial and harmful effects of dapagliflozin for the treatment of adults with type 2 diabetes who have experienced inadequate glycemic control on combination therapy with metformin and a sulfonylurea

Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2016, April 2016
Series:CADTH common drug review
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Summary:The objective of this review was to perform a systematic review of the beneficial and harmful effects of dapagliflozin for the treatment of adults with type 2 diabetes who have experienced inadequate glycemic control on combination therapy with metformin and a sulfonylurea
Physical Description:1 PDF file (ix, 62 pages) illustrations